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Enteric infection of mice with respiratory enteric orphan virus (reovirus) type 1, strain Lang elicits both
humoral and cellular immune responses. To investigate the role of CD81, a/b T-cell receptor (TCR)1 T cells
in mucosal immunity to an enteric pathogen, we examined immune responses and viral clearance following
enteric reovirus infection in C57BL/6, B6129F2, and b2-microglobulin-deficient (b2m2/2) mice. Analysis of
Peyer’s patch and lamina propria culture supernatants revealed a two- to threefold increase in levels of
reovirus-specific immunoglobulin A in b2m2/2 mice compared to normal controls. These data corresponded
to a similar increase in the frequency of virus-specific immunoglobulin A-producing cells in Peyer’s patches
and lamina propria and an increase in immunoglobulin G-producing cells in spleens from b2m2/2 mice
compared to controls. These increased humoral immune responses were not due to a difference in B-cell
populations because cell counts and flow cytometric analyses showed that b2m2/2 and control mice had
similar numbers and percentages of B cells in mucosal and systemic tissues. Analysis of cytokine message by
reverse transcriptase-PCR 5 and 10 days after infection revealed no difference in message level for transform-
ing growth factor beta, gamma interferon, interleukin-4, interleukin-5, or interleukin-6 for all mouse strains.
Virus tissue titers determined by plaque assay at 5 and 10 days after infection demonstrated that b2m2/2 mice
cleared reovirus from the small intestines with the same efficiency as control mice. Collectively, these data
suggest that CD81, a/b TCR1 T cells may regulate mucosal and systemic humoral immune responses to oral
infection with reovirus.
A large proportion of T cells in the gut-associated lymphoid
tissue (GALT) of normal mice are CD81. These CD81 T cells
are distributed throughout the three major lymphoid compart-
ments in the gastrointestinal tract, constituting approximately 2
to 5% of Peyer’s patch (PP) lymphocytes and 15% of lamina
propria (LP) lymphocytes (5, 20, 27). Among the lymphocytes
in the intraepithelial compartment, over 90% are CD81 (24,
25). Antigen-specific CD81 T cells are activated following en-
teric exposure to a wide range of pathogens such as Listeria
monocytogenes (18, 50), Salmonella typhimurium (60), rotavirus
(49), reovirus (38), Toxoplasma gondii (9), and Cryptosporidium
spp. (43). The generation of antigen-specific CD81 T cells in
GALT is thought to be important in resistance to infection
either by lysing infected cells (18, 43, 49, 60) or by producing
cytokines such as gamma interferon (IFN-g) (8, 18, 57). How-
ever, despite the hypothesized protective role for antigen-spe-
cific CD81 T cells, protection against intestinal infections with
pathogens such as rotavirus (21), reovirus (1), and Cryptospo-
ridium muris (44) occurs in the absence of functional CD81
T-cell-mediated immunity. Therefore, the exact role of CD81
T cells in clearing pathogens or preventing reinfection of the
intestine is still unclear.
In addition to the hypothesized role of CD81 T cells in
protection against enteric infection, there is evidence that in-
testinal CD81 T cells may also regulate mucosal immune re-
sponses in vivo and in vitro. CD81 T cells have been implicated
in the induction of tolerance to orally administered antigens
(63). In experimental autoimmune encephalomyelitis, adop-
tively transferred CD81 PP and spleen (SPL) cells from ani-
mals fed myelin basic protein mediate resistance to disease in
naive animals (10, 37, 56). These CD81 T cells appear to exert
their immunosuppressive effects, at least in part, by the pro-
duction of transforming growth factor beta (TGF-b) (11, 56).
In addition, it has been suggested that CD81 T cells can inhibit
T helper (Th) cell responses in vitro. Harriman et al. (26)
found that expansion of keyhole limpet hemocyanin (KLH)-
specific CD41 LP T cells was inhibited when CD81 LP T cells
were present in culture. Subsequent depletion of CD81 T cells
prior to culture resulted in the generation of long-lived, anti-
gen-specific Th cell lines. Similarly, Hornquist et al. (27) de-
scribed a possible role for CD81 T cells in the inhibition of
antigen-specific immunoglobulin A (IgA) and CD41 T-cell
responses in GALT. Following oral administration of KLH
and cholera toxin, CD81 T-cell-deficient mice had enhanced
KLH-specific IgA responses as well as increased IFN-g pro-
duction in LP cell culture supernatants. It has also been hy-
pothesized that CD81 T suppressor cells are selectively acti-
vated by major histocompatibility complex (MHC) class II
molecules expressed on the surface of intestinal epithelial cells
(4, 42). While these studies demonstrate that antigen-specific
humoral and cellular immune responses to soluble protein may
be regulated by CD81 T cells, little is known about the immu-
noregulatory effects of CD81 T cells following enteric infection
with a replicating antigen. A candidate agent for such studies
is respiratory enteric orphan virus (reovirus), a well-character-
ized enteric pathogen that has been extensively used to study
intestinal immune responses.
Enteric infection with reovirus elicits cellular and humoral
immune responses in GALT (16, 39, 41). Humoral mucosal
immunity is characterized by the production of virus-specific
IgA in PP and LP (39). CD81, a/b T-cell receptor (TCR)1
virus-specific precursor cytotoxic T lymphocytes (CTL) also
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develop in PP and the epithelium following reovirus infection
(15, 38–40). In addition, oral administration of UV-inactivated
reovirus induces oral tolerance (54).
In this study, we measured the local and systemic humoral
immune responses in reovirus-infected b2-microglobulin-defi-
cient (b2m2/2) mice. b2m2/2 mice are deficient in expres-
sion of MHC class I and therefore lack the majority of CD81,
a/b TCR1 T cells (32, 65). Thus, these animals provide a
model with which to study immune responses in the absence of
conventional CD81 T cells. Although systemic infection with
lymphocytic choriomeningitis virus (LCMV) (2, 36) and pul-
monary Sendai virus infection (29) resulted in increased hu-
moral immune responses in b2m2/2 mice, it is not well known
whether the intestinal immune response, with its poorly under-
stood mechanisms of regulation, is similarly enhanced in
b2m2/2 mice. Our data suggest that CD81, ab TCR1 T cells
may inhibit mucosal and systemic antibody responses following
enteric virus infection.
MATERIALS AND METHODS
Animals. Male C57BL/6, B6129F2 (F2), and b2m2/2 mice were purchased
from the Jackson Laboratory. b2m2/2 mice were also bred in our animal facility
from parental stock purchased from the Jackson Laboratory. Mice were housed
in specific-pathogen-free conditions, and reovirus-infected mice were housed in
a separate room in a laminar flow hood. All animals were used between 8 and 12
weeks of age. The b2m2/2 mice used in these studies are hybrids of the
C57BL/6 and 129 mouse strains (32, 65). Therefore, we have used both C57BL/6
control mice and the additional control strain F2 (30a).
Virus purification. Reovirus type 1, strain Lang stocks were grown in L929
cells at 34°C in a spinner flask in Eagle’s minimum essential medium for sus-
pension cultures (Whittaker Bioproducts, Walkersville, Md.) containing 5% fetal
bovine serum (FBS; HyClone, Logan, Utah), 2 mM L-glutamine (Sigma, St.
Louis, Mo.), and 100 U of penicillin, 0.1 mg of streptomycin, and 10 mg of
gentamicin (all from Whittaker Bioproducts), per ml. Third-passage reovirus was
purified from L929 cell lysates by extraction with 1,1,2-trichloro-1,2,2-trifloro-
ethane followed by CsCl gradient centrifugation. Plaque assays were used to
determine titers of purified virus as described by Cuff et al. (16).
Animal infections. Purified reovirus was suspended at a concentration of 6 3
108 PFU/ml in borate-buffered saline (pH 7.4) containing 2% gelatin (gel saline).
Mice were orally infected with 3 3 107 PFU of reovirus in 50 ml, using an oral
feeding tube.
Virus titers. Five and ten days after infection, b2m2/2 and control mice were
sacrificed by cervical dislocation, and PP, small intestines (SI), mesenteric lymph
nodes (MLN), and SPL were harvested. Tissues were placed in 3 ml of gel saline
and frozen and thawed three times. Tissues were then homogenized (Brinkmann,
Westbury, N.Y.) and sonicated (Misonix, Inc., Farmingdale, N.Y.). Serial 10-fold
dilutions of tissues were made in gel saline, and 100 ml of each dilution was
incubated on confluent L929 cell monolayers in 12-well plates (Costar, Cam-
bridge, Mass.) for 45 min at 34°C. Virus-infected monolayers were overlaid with
an equal volume of 2% agar and 23 medium 199 (Whittaker Bioproducts)
containing 10% FBS, 4 mM L-glutamine, and antibiotics. Plaque assays were
cultured for 7 days at 34°C, with additional overlays every 3 days. The final
overlay contained 0.02% neutral red (Sigma) to visualize plaques.
Lymphoid tissue fragment cultures. PP were cultured as previously described
previously (41). PPs were removed from the gut and intestines were cut longi-
tudinally. Intestinal contents were removed by washing the tissue at least three
times in Hanks’ balanced salt solution (HBSS) containing 0.1 M HEPES, 0.2%
NaHCO3, and 10 mg of gentamicin per ml. Tissues were then suspended in 5 mM
EDTA–HBSS and incubated for 30 min at 37°C. SI devoid of epithelium (here-
after referred to as LP) were then cultured in 5 ml of tissue culture medium
(TCM) consisting of RPMI 1640 (Whittaker Bioproducts) supplemented with
10% FBS, 2 mM L-glutamine, and antibiotics in six-well plates (Costar). Cultures
were incubated at 37°C and 5% CO2 for 5 days without further restimulation.
Following incubation, the supernatants were collected and reovirus-specific an-
tibody concentrations were measured by enzyme-linked immunosorbent assay
(ELISA).
ELISA for reovirus-specific and total antibody. Each well of 96-well ELISA
plates (Costar) was coated overnight at 4°C with 50 ml of either 5 3 1010 particles
of purified reovirus or 1 mg of goat anti-mouse Ig (heavy and light chain specific;
Southern Biotechnology, Birmingham, Ala.) per ml in 0.1 M NaHCO3. Plates
were washed twice with phosphate-buffered saline (PBS) supplemented with
0.5% Tween 20 (PBS-T) and blocked with 3% (wt/vol) bovine serum albumin
(Sigma) in PBS for 2 h at room temperature. Following two washes with PBS-T,
serial twofold dilutions of culture supernatants or serum were added to sample
wells (100 ml/well) and incubated overnight at 4°C. Plates were washed four times
with PBS-T and were reacted for 45 min at room temperature with 100 ml of
biotinylated goat antibody specific for murine IgA, IgG2a, or IgG2b (Southern
Biotechnology) at a concentration of 0.5 mg/ml in PBS supplemented with 10%
FBS. Following incubation, plates were washed six times, avidin-conjugated
peroxidase (0.25 mg/well; Sigma) was added, and the plates were incubated for 30
min at room temperature. Plates were washed eight times with PBS-T, 100 ml of
the substrate 2,29-azinobis-3-ethylbenzthiazoline-6-sulfonic acid (Sigma) was
added to each well, and color was developed for 20 min. Plates were read at 405
nm on an ELISA microplate reader (Bio-Tek Instruments Inc., Winooski, Vt.).
Quantitation of virus-specific and total antibody was accomplished by adding
serial twofold dilutions of known concentrations of purified mouse IgA, IgG2a,
or IgG2b (Southern Biotechnology) to wells coated with goat anti-mouse Ig
(heavy and light chain specific) to generate standard curves. Specificities of
antibodies were previously confirmed by ELISA and immunoblot analysis (41).
Lymphocyte isolation. Spleen lymphocytes were isolated by expressing organs
through a nylon screen (Tetko Inc., Briarcliff Manor, N.Y.) and lysing erythro-
cytes with Tris-buffered ammonium chloride (46). Single-cell suspensions were
washed three times with RPMI 1640 containing 5% FBS and antibiotics (here-
after referred to as wash medium) and resuspended in TCM.
PP lymphocytes were isolated by dissecting PP from the SI and mechanically
disassociating lymphocytes from the tissue using 18-gauge needles. Single-cell
suspensions were passed over nylon wool columns to remove tissue debris, and
recovered cells were washed three times in wash medium.
LP lymphocytes were isolated by using modifications of previously published
methods (33). The epithelium was removed from the SI by using EDTA as
described above. SI were then incubated in RPMI 1640 supplemented with 10%
FBS and 0.1% gentamicin for 30 min at room temperature. Tissues were digested
with collagenase (50 U/ml; Sigma), dispase grade II (0.3 to 0.5 mg/ml; Boehr-
inger Mannheim, Indianapolis, Ind.), soybean trypsin inhibitor (0.2 mg/ml; Sig-
ma), and DNase (1.6 mg/ml; Sigma) in RPMI 1640 supplemented with 10% FBS
and antibiotics for 60 min at 37°C. After digestion, tissue suspensions were
passed over nylon wool columns and washed twice with HBSS. This process was
repeated on the remaining undigested tissue. Lymphocytes from both digestions
were pooled and enriched on a discontinuous Percoll (Sigma) gradient. Cells
were resuspended in 42% Percoll, underlaid with 70% Percoll, and centrifuged
at 600 3 g for 20 min at 4°C. Lymphocytes were removed from the 42%/70%
interface and washed three times in wash medium.
ELISPOT assays. Enzyme-linked immunospot (ELISPOT) analyses were per-
formed by using modifications of methods of Kramer and Cebra (33). Each well
of 96-well nitrocellulose plates (Millipore, Bedford, Mass.) was coated overnight
at 4°C with 50 ml of either 2.0 3 1011 particles of reovirus or 10 mg of goat
anti-mouse Ig per ml in sterile PBS. Each well was washed three times with 200
ml of sterile PBS and blocked for 2 h at 37°C with 200 ml of RPMI 1640
containing 10% FBS. SPL and PP cells were diluted to 106, 105, and 104 cells/ml,
and LP cells were diluted to 105, 104, and 103 cells/ml, in TCM. One hundred
microliters of the cell suspensions was placed in the wells, and the plates were
incubated for 4 h at 37°C and 5% CO2. Plates were washed six times with PBS-T
and incubated overnight at 4°C with 100 ml of either alkaline phosphatase-
conjugated anti-mouse IgA and IgG2a or biotinylated goat anti-mouse IgG2b,
diluted 1:250 in 1% bovine serum albumin–PBS-T, per well. Plates were washed
eight times with PBS-T, and IgA and IgG2a plates were developed with substrate
solution containing 0.15 mg of 5-bromo-4-chloro-3-indolylphosphate per ml, 0.30
mg of nitroblue tetrazolium per ml, and 5 mM MgCl2 in 100 mM Tris buffer
(SIGMA FAST BCIP/NBT; Sigma). Plates incubated with biotinylated goat
anti-mouse IgG2b were incubated with 100 ml of avidin-peroxidase (2.5 mg/ml)
per well for 90 min at room temperature before development with substrate
solution containing 3,39-diaminobenzidine (0.7 mg/ml) and urea H2O2 (2.0 mg/
ml) in 0.06 M Tris buffer (SIGMA FAST DAB; Sigma). Plates were developed
for 15 to 20 min, and the reaction was stopped with distilled H2O. A dissecting
microscope was used to count antibody spot-forming cells (SFC).
Flow cytometric analysis. Cell suspensions of PP, LP, and SPL were stained
with either fluorescein isothiocyanate-conjugated antibody specific for murine
B220 or CD8a (both from Caltag Laboratories, San Francisco, Calif.) or phy-
coerythrin-conjugated antibody specific for murine CD4 or Thy1.2 (both from
Pharmingen, San Diego, Calif.). Cells were incubated with antibodies for 30 min
at 4°C in the dark. Following two washes with 1% FBS in PBS (vol/vol), cells were
fixed in 100 ml of 0.4% paraformaldehyde in PBS (wt/vol) and analyzed with a
FACscan (Becton Dickinson, San Jose, Calif.). PP cells contained #1% g/d
TCR1 cells, indicating that PP lymphocyte preparations were not significantly
contaminated with intraepithelial lymphocytes.
RT-PCR for cytokine mRNA in PP. Total cellular RNA was isolated by using
modifications of methods described by Chirgwin et al. (12). Five and ten days
after infection, total RNA from b2m2/2 and C57BL/6 PP was isolated by
placing whole tissue in 1.0 ml of RNAzol-B solution (Tel-Test Inc., Friendswood,
Tex.) containing guanidinium thiocyanate and phenol. RNA was extracted from
dissolved tissues by adding 100 ml of chloroform to each sample tube. Five
micrograms of purified RNA was treated with 1 U of DNase per sample as
instructed by the manufacturer (Promega, Milwaukee, Wis.) for 1 h at 37°C.
First-strand cDNA was synthesized in a final volume of 10 ml by reacting each
sample with 12.5 U of RNase inhibitor, 0.5 ml of deoxynucleotide triphosphate
(dNTP) mixture (containing 10 mM each ATP, CTP, GTP, and TTP), 0.5 ml of
random primer (0.1 A260 units/ml), 10 U of reverse transcriptase (RT), and 2 ml
of reaction buffer (all from Boehringer Mannheim). Samples were reacted for 1 h
at 42°C and were stored at 220°C until used in PCR analyses.
VOL. 71, 1997 REOVIRUS-SPECIFIC HUMORAL IMMUNITY IN b2m2/2 MICE 5783
 on S
eptem







For PCR, 2 ml of cDNA was reacted in a total volume of 25 ml with 0.125 U
of AmpliTaq polymerase per ml, 2 ml of dNTP mixture (2.5 mM each dNTP), 0.4
mM 59 primer, 0.4 mM 39 primer, and 2.5 ml of 10 3 PCR buffer (100 mM
Tris-HCl, 500 mM KCl, 15 mM MgCl2, 0.01% gelatin, pH 8.3 [Perkin Elmer,
Norwalk, Conn.]). Commercially available primers for IFN-g, TGF-b, interleu-
kin-4 (IL-4), IL-5, and IL-6 (Clontech Laboratories, Palo Alto, Calif.) were used.
Primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were pre-
pared by the West Virginia University DNA Core Facility and consisted of the
GAPDH 1 primer sequence 59 TGA AGG TCG GTG TGA ACG GAT TTG G
39 and the GAPDH 2 primer sequence 59 ACG ACA TAC TCA GCA CCA
GCA TCA C 39 (55). Positive controls consisted of reaction mixtures containing
1 ml of specific template for each cytokine, which was provided by the manufac-
turer. Conditions for PCR consisted of one cycle of 94°C for 4 min, 55°C for 2
min, 72°C for 2 min, 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 1.5 min
and one cycle of 94°C for 45 s, 55°C for 1 min, and 72°C for 7 min. All PCRs were
performed with an excess of enzyme, primers, and deoxyribonucleotides. Sam-
ples were stored at 4°C until they were analyzed by gel electrophoresis on a 1.5%
agarose gel. Specific bands were visualized by examining ethidium bromide-
stained gels under UV light. Specificity of the reaction was confirmed by com-
paring band size to positive controls provided by Clontech and Southern blot
analysis of PCR products by using specific probes.
RESULTS
Reovirus-specific IgA responses in GALT from b2m2/2
and control mice. Virus-specific IgA was significantly increased
in PP and LP fragment culture supernatants from b2m2/2
mice compared to controls (Fig. 1). While there was variation
in antibody output between experiments, six separate experi-
ments demonstrated that virus-specific IgA concentrations
were two- to threefold higher in culture supernatants from
b2m2/2 mice than in control strain culture supernatants.
There was no difference among the three strains of mice in the
amount of total IgA in the culture supernatants (data not
shown).
Cellularity and phenotype distribution in secondary lym-
phoid tissues from b2m2/2 and control mice. Lymphocyte
cell counts and flow cytometric analyses were used to deter-
mine whether the increase in virus-specific IgA in fragment
culture supernatants was due to increases in cellularity or B-
cell distribution. PP, LP, and SPL from b2m2/2 mice contain
cell numbers similar to those in C57BL/6 and F2 controls
(Table 1). The percentages of B2201 cells were similar for
b2m2/2 and controls in SPL and PP; however, F2 mice had a
significantly higher percentage of B2201 cells in LP compared
to b2m2/2 and C57BL/6 mice. Percentages of Thy1.21 cells in
SPL, PP, and LP from b2m2/2 and control mice were similar.
However, b2m2/2 mice had an increased percentage (P ,
0.04) and absolute number (P , 0.02) of CD41 T cells in SPL
(Table 1). In addition, in two of two separate experiments, the
percentage of CD41 T cells in PP from b2m2/2 mice was
higher than in controls, although the difference was not statis-
tically significant when the data from both experiments were
combined.
Increased frequencies of reovirus-specific IgA antibody-pro-
ducing cells in b2m2/2 mice. The increase in virus-specific
IgA without an increase in the number of B cells suggested that
FIG. 1. Reovirus-specific IgA concentrations in PP and LP fragment culture
supernatants from b2m2/2 (open bars), C57BL/6 (closed bars; A), and F2
(hatched bars; B) mice. Ten days after oral infection with reovirus, fragment
cultures of PP and LP were cultured for 5 days without further restimulation.
Reovirus-specific IgA concentrations were determined by specific ELISA. Bars
represent the means and standard errors for four to five individual mice per
group. Data shown are from two representative experiments of six comparing
b2m2/2 to either the C57BL/6 or F2 control mouse strain. An asterisk denotes
significantly higher virus-specific IgA concentrations as determined by Student’s
t test (P , 0.05).
TABLE 1. Cellularity and lymphocyte distribution in tissues from reovirus-infected mice
Tissue Mouse strain Cell count (10
6)
(6SEM)
% Positive cells (6SEM)a
B220 Thy1.2 CD4 CD8
SPL b2m2/2 90.0 (9.0) 41.9 (2.3) 29.3 (2.4) 33.5 (2.5)b ,1.0
C57BL/6 76.8 (14.4) 41.8 (3.3) 33.7 (2.4) 21.0 (0.0) 10.5 (2.5)
F2 80.0 (4.3) 39.5 (2.4) 38.5 (7.5) 22.0d 8.0d
PP b2m2/2 6.2 (0.7) 63.0 (2.2) 20.3 (1.9) 25.0 (4.0) ,1.0
C57BL/6 6.1 (0.6) 68.7 (1.8) 19.7 (7.7) 16.0 (8.0) 4.0 (2.0)
F2 6.1 (0.8) 67.8 (3.1) 15.5 (2.5) NDe ND
LP b2m2/2 1.8 (0.6) 44.6 (8.7) 36.2 (4.8) ND ND
C57BL/6 1.6 (0.5) 41.4 (6.0) 43.4 (4.4) ND ND
F2 0.7 (0.4) 67.8 (3.1)c 41.0 (7.2) ND ND
a Surface phenotypes of pooled lymphocytes from reovirus-infected mice were determined by flow cytometric analysis (Materials and Methods). Except where
indicated, data represent the means and standard errors for two to eight separate experiments.
b Value is significantly greater than C57BL/6 control value (P , 0.04) as determined by Student’s t test.
c Value is significantly greater than b2m2/2 and C57BL/6 values (P , 0.05) as determined by analysis of variance.
d Value obtained from one experiment.
e ND, not determined.
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there may be a higher frequency of reovirus-specific antibody-
producing cells in PP and LP in b2m2/2 mice. Therefore, we
performed ELISPOT assays to determine frequencies of virus-
specific antibody-producing cells. PP from b2m2/2 mice had
a two- to sevenfold higher frequency of virus-specific IgA SFC
compared to C57BL/6 and F2 controls (Fig. 2A). In addition,
LP lymphocytes from b2m2/2 mice had 1.5- to 7-fold higher
frequencies of virus-specific IgA SFC compared to controls
(Fig. 2B). Similar results were found at day 17 postinfection
(data not shown).
Systemic humoral immunity following reovirus infection of
b2m2/2 and control mice. Because the intestinal immune
responses were greater in b2m2/2 mice than in controls, we
determined whether b2m2/2 mice also exhibited augmented
systemic virus-specific IgG responses. The frequencies of virus-
specific IgG2a- and IgG2b-producing cells in pooled spleno-
cyte populations were determined by ELISPOT 10 days after
infection. b2m2/2 mice had significantly higher frequencies of
both virus-specific IgG2a and IgG2b SFC compared to control
mice (Fig. 3). Virus-specific serum antibody concentrations did
not correspond to the increased frequency of virus-specific IgG
SFC observed in b2m2/2 mice. b2m2/2 mice had similar
concentrations of virus-specific IgG2a (1,096.7 6 328.7 ng/ml)
compared to C57BL/6 (588.3 6 50.4 ng/ml) and F2 (1,301.0 6
988.3 ng/ml) controls. Virus-specific IgG2b responses were ap-
proximately 10-fold lower in b2m2/2 mice (3,783.3 6 354.4
ng/ml) compared to C57BL/6 mice (33,650.0 6 6,818.5 ng/ml)
but were similar to responses in F2 mice (4,780.0 6 1,370.9
ng/ml) (Fig. 4).
RT-PCR analysis of cytokine-specific mRNA in PP from
reovirus-infected mice. The increased frequency of virus-spe-
cific B cells in b2m2/2 mice led us to hypothesize that altered
cytokine production in b2m2/2 mice resulted in enhanced
antigen-specific humoral immunity. Relative levels of mRNA
for TGF-b, IFN-g, IL-4, IL-5, and IL-6 were assessed by RT-
PCR in PP, the initial site of reovirus infection and initiation of
the IgA immune response (14, 64). Specific mRNAs for TGF-b
and IL-4 were present 5 and 10 days after infection (Fig. 5 and
data not shown). In addition, no mRNA for IFN-g, IL-5, or
IL-6 was detected in PP 5 or 10 days after infection in either
mouse strain. Image analysis of scanned gels revealed no sig-
nificant difference in relative TGF-b and IL-4 mRNA signals
between b2m2/2 and C57BL/6 mice 5 and 10 days postinfec-
tion (data not shown).
Reovirus titers in lymphoid tissue. To determine whether
CD81, a/b TCR1 T cells are necessary for efficient clearance
of replicating reovirus from mucosal and systemic lymphoid
tissues, reovirus titers were determined in PP, SI, MLN, and
SPL 5 and 10 days after infection. Virus titers in PP revealed
that b2m2/2 and C57BL/6 mice clear reovirus later than day
10, whereas F2 mice had no measurable virus 10 days after
FIG. 3. Frequencies of reovirus-specific IgG2a (A) and IgG2b (B) SFC per
106 B2201 cells from b2m2/2 (open bars), C57BL/6 (closed bars), and F2
(hatched bars) mice. Spleen lymphocyte pools from three mice per group were
assayed by ELISPOT for reovirus-specific IgG-secreting cells 10 days after oral
reovirus infection. The data are from four separate experiments comparing
b2m2/2 to C57BL/6 mice and/or F2 controls. Bars represent the means and
standard deviations for duplicate wells. An asterisk denotes a significantly lower
frequency of virus-specific IgG SFC for control mice compared to b2m2/2 mice
as determined by either Student’s t test (experiments 1 and 2 [P , 0.05]) or
analysis of variance (experiments 3 and 4 [P , 0.05]). In all experiments, there
was no difference among b2m2/2 and control mice in the percentage or abso-
lute number of B2201 cells in SPL calculated from the data in Table 1. ND, not
determined.
FIG. 2. Frequencies of reovirus-specific IgA SFC per 106 total IgA SFC in PP
(A) and LP (B) from b2m2/2 (open bars), C57BL/6 (closed bars), and F2
(hatched bars) mice. PP and LP lymphocyte pools from three mice per group
were assayed by ELISPOT for reovirus-specific IgA-secreting cells 10 days after
oral infection with reovirus. PP data represent four separate experiments com-
paring b2m2/2 to C57BL/6 mice in which two experiments include the F2
control. LP data represent three separate experiments comparing b2m2/2 to
C57BL/6 mice in which two experiments include the F2 control. Bars represent
the means and standard deviations for duplicate wells. An asterisk denotes a
significantly lower frequency of virus-specific IgA SFC for control mice com-
pared to b2m2/2 mice as determined by Student’s t test (A, experiments 1 and
2; B, experiment 1 [P , 0.05]) or analysis of variance (A, experiments 3 and 4; B,
experiments 2 and 3 [P , 0.05]). In all experiments, there was no difference
among b2m2/2 and control mice in the frequency of total IgA SFC from both
PP and LP (data not shown). ND, not determined.
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infection (Fig. 6). In SI, C57BL/6 mice had significantly higher
virus titers (log10 3.23 6 0.08) 10 days after infection compared
to b2m2/2 mice (three of six positive; log10 2.54 6 0.06).
However, SI virus titers in b2m2/2 mice were not different
from those in F2 control mice (three of six positive; log10
2.82 6 0.17). Both b2m2/2 and control mice demonstrated
little replicating virus in the MLN and SPL 5 days after infec-
tion. Most of the mice cleared virus from these tissues within
10 days after infection.
DISCUSSION
We examined the immune responses to enteric reovirus in-
fection in CD81, a/b TCR1 T-cell-deficient b2m2/2 mice in
order to gain a better understanding of the role of CD81 T
cells in generating or regulating virus-specific intestinal immu-
nity. PP and LP fragment culture supernatants from b2m2/2
mice had two- to threefold-higher concentrations of virus-spe-
cific IgA, but no difference in total IgA, compared to both
C57BL/6 and F2 controls 10 days after infection. The increase
in virus-specific IgA was not due to differences in cellularity or
B-cell percentages in PP and LP but corresponded to increases
in the frequency of reovirus-specific IgA-producing cells per
106 total IgA-producing cells in GALT. These data are consis-
tent with other studies that demonstrate increases in antigen-
specific IgA in mice lacking CD81 T cells. Hornquist et al. (27)
found that CD81 T-cell-deficient mice had a higher frequency
of KLH-specific IgA-producing cells in LP following oral ex-
posure to KLH and cholera toxin. In addition, Hyland et al.
(29) reported that intranasal infection with Sendai virus results
in an increase in virus-specific IgA antibody-forming cells in
the SPL, mediastinal lymph nodes, and bone marrow from
b2m2/2 mice. In both of these studies, the authors suggested
that the CD81 T-cell population may regulate the production
of antigen-specific IgA (27, 29). The mechanism(s) of such
regulation remains to be elucidated.
In contrast to those reports and the present study, intranasal
influenza virus infection in b2m2/2 mice resulted in no en-
hancement of virus-specific antibody 3 weeks after infection
(3). Franco and Greenberg (21) found a delayed appearance of
virus-specific IgA in rotavirus-infected b2m2/2 mice, but
there was no significant difference in rotavirus-specific IgA by
FIG. 4. Reovirus-specific IgG2a (A) and IgG2b (B) in serum from b2m2/2
(circles), C57BL/6 (squares), and F2 (triangles) mice. Virus-specific IgG concen-
trations were determined by ELISA 10 days after oral reovirus infection. Each
symbol represents an individual mouse, and data shown are combined from two
experiments. Virus-specific antibody concentrations were determined by compar-
ison to the appropriate standard curve as described in Materials and Methods.
FIG. 5. RT-PCR analysis of cytokine message in PP from b2m2/2 and
C57BL/6 mice 5 days after infection with 3 3 107 PFU of reovirus type 1, strain
Lang. Total RNA was extracted from the PP of three mice per group. Following
generation of first-strand cDNA, cytokine and GAPDH messages were amplified
by reaction with specific primers as described in Materials and Methods. Am-
plified DNA was electrophoresed on a 1.5% agarose gel and visualized with
ethidium bromide. ctrl, control.
FIG. 6. Reovirus titers in tissues from b2m2/2 (circles), C57BL/6 (squares),
and F2 (triangles) mice 5 and 10 days after oral infection. Symbols and error bars
represent the means and standard errors of positive virus titers as determined by
plaque assay for six to seven mice per group. Numbers above symbols denote the
numbers of positive animals per total number of animals assayed. The dotted line
represents the limit of detection for the plaque assay (102.48 PFU/organ). An
asterisk denotes significantly different virus titers as determined by analysis of
variance.
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day 10 after infection. Because we did not examine virus-
specific IgA prior to day 10, it is unknown whether a kinetic
difference in antibody appearance exists in b2m2/2 mice fol-
lowing enteric reovirus infection. However, serum IgG appears
by 7 days postinfection in both b2m2/2 and control mice (data
not shown). Therefore, it is possible that the production and/or
enhancement of virus-specific IgA is dependent on the type of
virus as well as the initial route of infection.
In addition to increased frequencies of virus-specific IgA-
producing cells in the GALT, we observed enhanced frequen-
cies of IgG2a and IgG2b SFC in SPL. The frequencies of
IgG1-producing cells was not determined because oral reovirus
infection in H-2b mice does not elicit substantial virus-specific
serum IgG1 (41). Reovirus-specific serum antibody responses
were not elevated in b2m2/2 mice. The significantly elevated
IgG2b responses in C57BL/6 mice compared to b2m2/2 and
F2 mice did not correspond to an increased antibody-forming
cell response in SPL. This difference might suggest that other
lymphoid tissue such as bone marrow or MLN substantially
contribute to the IgG2b serum levels in C57BL/6 mice. Alter-
natively, strain differences in IgG2b catabolism might account
for the increased concentrations of serum antibody in C57BL/6
mice because IgG2b has a shorter serum half-life than other
IgG subclasses (51). We did not examine total IgG2b concen-
trations in these experiments.
Alterations in systemic antibody responses to other virus
infections have been found in the absence of CD81 T cells.
Sendai virus infection in b2m2/2 mice resulted in increased
frequencies of IgG2a antibody-forming cells in mediastinal
lymph nodes without a concurrent increase in serum antibody
titer (29). Likewise, infection with LCMV resulted in increased
numbers of IgG-producing cells in SPL from CD81 T-cell-
deficient mice with no significant difference in serum antibody
(2, 36). In contrast to these reports and our study, Spriggs et al.
(59) found that intraperitoneal vaccinia virus infection in
b2m2/2 mice resulted in decreased virus-specific serum IgG
responses. Additionally, influenza virus-specific antibody re-
sponses are decreased in b2m2/2 mice 9 days and 3 weeks
after intranasal immunization with recombinant vaccinia virus
(3, 19). These latter studies did not report frequencies of virus-
specific antibody-producing B cells in lymphoid tissue. It has
been hypothesized that serum antibody homeostasis is main-
tained by recirculating Ig that is bound to an Fc receptor that
closely resembled the neonatal Fc receptor (FcRn) and is con-
stitutively expressed in most tissue of the adult mouse (7, 23,
30, 45, 51, 52, 58). Like the MHC class I molecule, the FcRn
requires association with b2-microglobulin to be efficiently ex-
pressed on the cell surface (58). b2m2/2 mice do not have
normal expression of the FcRn, and as a consequence, serum
IgG concentrations and half-lives are reduced (23, 30). Thus,
the lack of parallel increases in virus-specific IgG-producing
cells in SPL and virus-specific IgG serum levels in b2m2/2
mice may not be due to the absence of MHC class I-restricted
CD81 T cells, rather the lack of b2-microglobulin and appro-
priate FcRn function. Increases in the frequency of virus-spe-
cific IgG-producing cells in the periphery do correspond to
increases in IgA responses in GALT. Therefore, if CD81 T
cells regulate mucosal immune responses, they might also reg-
ulate systemic immunity.
We found an increase in the percentage of CD41 T cells in
the SPL and PP in b2m2/2 mice compared to controls. Ad-
ditionally, the absolute number of CD41 T cells was increased
in the spleens, reflecting the absence of CD81 T cells. This
increase in CD41 T cells could account for the increased an-
tibody responses by providing more T-cell help for humoral
immunity. This hypothesis would be supported only if there is
an increase in the frequency of antigen-specific Th cells in the
spleen or other lymphoid tissue. Experiments are in progress to
determine the frequency of virus-specific helper cells and
mechanisms of T-cell function in b2m2/2 mice.
One mechanism by which CD81 T cells might regulate im-
mune responses is through the production of cytokines (31).
Our laboratory (6) and others (35) have found that PP CD81
T cells make IFN-g. Although IFN-g is not thought to be
directly involved in IgA responses in GALT, it can down reg-
ulate Th2-associated cytokines such as IL-4, IL-5, IL-6, and
IL-10, which, together with TGF-b, are hypothesized to be
integral in the maturation of IgA-producing B cells (34).
Therefore, we originally hypothesized that IFN-g produced by
PP CD81, a/b TCR1 T cells might serve to inhibit antibody
responses in GALT. Thus, we expected to observe decreases in
IFN-g and increases in other IgA-associated cytokines in
b2m2/2 mice compared to controls. In two separate experi-
ments, RT-PCR analyses revealed that b2m2/2 and C57BL/6
mice had similar levels of relative mRNA for TGF-b and IL-4.
No mRNA for IL-5, IL-6, or IFN-g was detected at day 5 or 10
after infection. Amplification of cytokine mRNA has been
used to assess cytokine function in GALT (35, 48, 61, 62) even
though mRNA levels may not correspond precisely to protein
levels. We failed to detect substantial differences in cytokine
mRNA for several cytokines that have been implicated in reg-
ulating IgA responses in the PP, the initial site of infection by
reovirus (64). Analysis of mRNA for other cytokines such as
IL-10 or IL-12, or cytokine analysis of other lymphoid tissues,
may provide information regarding the mechanism of the en-
hanced IgA response in CD81, a/b TCR1 T-cell-deficient
mice. Additional studies using cytokine knockout mice or ma-
nipulation of cytokine levels would also be useful in defining
the role of particular cytokines in the immune response to
enteric virus infection.
Although b2m2/2 mice are deficient in the ability to gen-
erate virus-specific CTL responses (53), they efficiently clear
reovirus from GALT, and virus did not disseminate substan-
tially. The F2 control mice appeared to clear virus more rapidly
from PP than C57BL/6 and b2m2/2 mice. Virus in the PP at
day 10 could contribute to the enhanced IgA response in
b2m2/2 mice by providing prolonged antigen exposure to the
PP. This explanation is unlikely because there was no differ-
ence between the virus titers in b2m2/2 and C57BL/6 mice,
yet there was a difference in IgA responses in those mice. Our
results are consistent with those of Barkon et al. (1), who
examined infection of b2m2/2 mice with reovirus clone 9, a
strain of serotype 3 reovirus. However, they did not examine
viral clearance in PP and intestines separately. In addition, we
examined virus titers in MLN and SPL, which are likely the
sites of priming of the systemic antibody response to oral
reovirus infection (41). Barkon et al. (1) cautioned against
assuming that virus-specific CD81 precursor CTL are not im-
portant in protection against reovirus and suggested that com-
pensation of the immune response could be responsible for
efficient clearance in these mutant mice. Our data support this
conclusion and suggest that increased production of virus-spe-
cific IgA may allow b2m2/2 mice to clear reovirus at rates
similar to those of control mice. In addition, b2m2/2 mice
develop MHC class II-restricted CD41 CTL in pulmonary
lymphoid tissue following infection with influenza virus (3, 17)
and Sendai virus (28) and in SPL following LCMV infection
(47). Whether CD41 CTL develop in GALT as a compensa-
tory mechanism in b2m2/2 mice following reovirus infection
is not yet known. However, it is conceivable that such T cells do
develop and may function to clear virus from infected tissues.
In addition to CD41 CTL, it is possible that CD81, g/d
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TCR1 T cells, which make up the majority of the intraepithe-
lial lymphocytes in b2m2/2 mice (13), kill reovirus-infected
cells or provide increased help for antibody responses. Because
g/d TCR1 T-cell-deficient mice have decreased IgA responses
to tetanus toxoid and cholera toxin (22), it is thought that g/d
TCR1 intraepithelial cells may enhance IgA immune re-
sponses. An increase in the relative frequency of g/d TCR1
intraepithelial cells might provide additional T-cell help to
amplify the virus-specific antibody response in b2m2/2 mice.
However, it should be again noted that although we observe
increases in virus-specific IgA-producing cells, the numbers of
total IgA-producing cells are the same in b2m2/2 and control
mice.
Various hypotheses have been proposed to explain the
mechanism(s) by which CD81 T cells regulate antigen-specific
humoral immunity. CD81 CTL may down regulate antibody
responses during viral infection by lysing antigen-presenting
cells or antibody-producing B cells (2). Reovirus-specific
CD81 CTL may lyse virus-infected cells, thus reducing viral
load and decreasing the activation of Th and B cells. Because
no difference in virus titers was observed among b2m2/2 mice
and control animals, increases in virus-infected cells would not
explain augmented IgA responses in mutant mice. Inefficient
clearance of viral antigen could result in prolonged activation
of virus-specific Th cells in b2m2/2 mice, which may then
enhance virus-specific B-cell responses. Alternatively, CD81 T
cells have been described as suppressors of immune responses
(31, 63). Harriman et al. (26) demonstrated that KLH-specific
Th cells from LP could be expanded only if CD81 T cells were
first depleted, suggesting that CD81 T cells from GALT inhibit
Th cell proliferation. We are currently conducting studies to
examine the immunoregulatory effects of GALT CD81 T cells
on MHC class II expression, antigen presentation, and the
frequency of virus-specific Th cells.
In conclusion, intestinal reovirus infection induces enhanced
virus-specific mucosal IgA and systemic IgG responses in
b2m2/2 mice compared to control animals. These enhanced
immune responses are not directly related to differences in the
absolute number of B cells in lymphoid tissue and are not due
to differences in TGF-b, IFN-g, IL-4, IL-5, or IL-6 production
in PP. Collectively, these data support the hypothesis that
MHC class I-restricted CD81, a/b TCR1 T cells can act as
immunoregulatory cells of humoral immune responses during
enteric infection.
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